Oak Asset Management LLC Cuts Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Oak Asset Management LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% in the 1st quarter, HoldingsChannel reports. The fund owned 8,085 shares of the medical equipment provider’s stock after selling 180 shares during the quarter. Intuitive Surgical accounts for 1.2% of Oak Asset Management LLC’s portfolio, making the stock its 28th biggest position. Oak Asset Management LLC’s holdings in Intuitive Surgical were worth $3,227,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. LVW Advisors LLC boosted its holdings in Intuitive Surgical by 13.3% during the 1st quarter. LVW Advisors LLC now owns 1,201 shares of the medical equipment provider’s stock valued at $479,000 after acquiring an additional 141 shares during the period. Optas LLC purchased a new stake in Intuitive Surgical during the 1st quarter valued at about $220,000. New Mexico Educational Retirement Board boosted its holdings in Intuitive Surgical by 14.3% during the 1st quarter. New Mexico Educational Retirement Board now owns 20,842 shares of the medical equipment provider’s stock valued at $8,318,000 after acquiring an additional 2,600 shares during the period. Atticus Wealth Management LLC boosted its holdings in Intuitive Surgical by 166.3% during the 1st quarter. Atticus Wealth Management LLC now owns 237 shares of the medical equipment provider’s stock valued at $95,000 after acquiring an additional 148 shares during the period. Finally, Vicus Capital purchased a new stake in Intuitive Surgical during the 1st quarter valued at about $360,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total transaction of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares in the company, valued at $9,385,753.30. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Craig H. Barratt sold 1,400 shares of the business’s stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,956 shares of company stock worth $6,927,011. 0.80% of the stock is owned by insiders.

Intuitive Surgical Stock Down 0.1 %

ISRG opened at $444.85 on Monday. The business has a 50 day moving average of $403.83 and a 200-day moving average of $383.50. The stock has a market cap of $157.79 billion, a PE ratio of 80.30, a PEG ratio of 5.75 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $254.85 and a 52 week high of $447.11.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s quarterly revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.00 earnings per share. Equities analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ISRG. Citigroup increased their target price on Intuitive Surgical from $428.00 to $462.00 and gave the company a “buy” rating in a report on Wednesday, April 3rd. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Piper Sandler lifted their price objective on Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a research report on Friday, April 19th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. Finally, Robert W. Baird cut their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research report on Friday, April 19th. Five analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $403.67.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.